Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / #OTHER
-
Shares outstanding
-
67M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
52.9M
-
Shares change
-
+1.48M
-
Total reported value, excl. options
-
$389M
-
Value change
-
+$11.2M
-
Number of buys
-
41
-
Number of sells
-
-40
-
Price
-
$7.34
Significant Holders of Generation Bio Co. - #OTHER (GBIO) as of Q1 2022
96 filings reported holding GBIO - Generation Bio Co. - #OTHER as of Q1 2022.
Generation Bio Co. - #OTHER (GBIO) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.9M shares
of 67M outstanding shares and own 79% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (8.76M shares), FMR LLC (8.55M shares), Atlas Venture Life Science Advisors, LLC (8.28M shares), Bellevue Group AG (3.68M shares), VANGUARD GROUP INC (3.55M shares), FARALLON CAPITAL MANAGEMENT LLC (3.5M shares), Artal Group S.A. (2.81M shares), BVF INC/IL (2.8M shares), Yiheng Capital Management, L.P. (2.6M shares), and Casdin Capital, LLC (1.32M shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.